JPMorgan Chase & Co. reissued their overweight rating on shares of Relx (LON:REL - Free Report) in a research report report published on Thursday morning, Marketbeat.com reports. The firm currently has a GBX 4,550 ($57.81) price objective on the stock.
Relx Price Performance
REL traded up GBX 12 ($0.15) during trading on Thursday, reaching GBX 3,784 ($48.08). The company's stock had a trading volume of 2,544,716 shares, compared to its average volume of 5,281,570. The company has a market cap of £70.38 billion, a price-to-earnings ratio of 3,794.31, a PEG ratio of 2.69 and a beta of 0.48. The firm has a fifty day simple moving average of GBX 3,630.96 and a two-hundred day simple moving average of GBX 3,566.58. Relx has a 1 year low of GBX 3,004.46 ($38.18) and a 1 year high of GBX 3,796.70 ($48.24). The company has a quick ratio of 0.45, a current ratio of 0.48 and a debt-to-equity ratio of 218.66.
Insider Transactions at Relx
In other news, insider June Felix bought 1,400 shares of the business's stock in a transaction on Monday, September 30th. The shares were bought at an average price of GBX 3,504 ($44.52) per share, with a total value of £49,056 ($62,332.91). Insiders own 0.42% of the company's stock.
About Relx
(
Get Free Report)
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
Further Reading
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.